tech companies in our system
accelerator & innovation partners
target fund size seed & series A
condition • selectivity • follow on
NIT identifies, validates, invests in, and supports specific, carefully selected Seed-stage technology companies in Northern Israel, working through a strategic coalition and leading domain experts.
The fund focuses on HealthTech, Dual-Use, AgTech, and Industrial Technologies with global growth potential.
$30 million
Seed & Series A
$250K–$1.5M
Up to $2M
12–15 companies
Global tech leaders • Unicorn success stories • World-class R&D • Leading hospitals
More ownership. More time. Better entry pricing. Enabled by lower operating costs, lower churn, and regional incentives.
A hands-on team with deep roots, strong deal flow, and close support for founders.
Investment opportunities are evaluated and validated through NIT’s Alliance of industry, healthcare, research, and venture partners.
Global technology companies, research centers, hospitals, accelerators, and advanced industry.
Every venture dollar goes ~30% further
Investment advantage
A region with proven technology successes and the foundations for building globally relevant companies.







NIT focuses on sectors where Northern Israel has clear structural advantages:

Medtech Solutions

Health Technology

Irrigation & Water Solutions

Hospital & Clinical Innovation

Agriculture & Food Tech

IP Strategy & Patent Protection

VC Coalition Life Sciences Investments

Audit, Advisory & Capital Solutions
These sectors align with the region’s engineering depth, clinical infrastructure, advanced industry, and applied research capabilities.
Local presence and deep regional relationships create early visibility into selected companies before broader market exposure.
NIT uses its strategic coalition and leading domain experts to assess technology, market potential, clinical or industrial relevance, and investment readiness.
Selective Seed-stage investment focused on companies with strong technology, capital efficiency, and global growth potential.
Hands-on support through partners, pilots, commercial introductions, non-dilutive capital strategy, and investor readiness.
Preparing companies for U.S. and international markets, strategic partnerships, and future institutional financing.
These sectors align with the region’s engineering depth, clinical infrastructure, advanced industry, and applied research capabilities.
NIT is designed to help selected Northern Israeli technology companies become better prepared for growth, partnerships, international expansion, and future institutional financing.
Through coalition-based validation, commercial support, non-dilutive capital strategy, investor readiness, and access to U.S. and global business networks, NIT aims to strengthen each company’s path from early promise to scalable opportunity.
Innovation | Tech | Legal | Cross-functional
LLB, BSc, MA Law. Founder of NIT, ex-COO/CEO in tech and industry. Partner at ESBM & Co, advising startups on tech, IP, law, and growth.
Business | M&As ,VC benchmarks I Finance
WeFund CEO, ex-Intel exec with M&A experience on both acquired and acquirer sides. Advisor to startups and investors, leading the VC 101 school.
Leadership | MedTech | Investments | Innovation
DeepTech | Investments | Innovation | Aerospace
Innovation | MedTech | Nanotechnology | AI
Clinical OD | MedTech | Validation
Entrepreneur | Investor | Business Development
Ventures | Capital | Investment | Exits | AI
People | Strategy | Execution | Investor
Finance | Fund Operations | Capital Management
AI | SaaS | Innovation | Fintech